{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:50:10Z","timestamp":1787579410600,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020552","name":"Ministry of Higher Education, Research and Innovation","doi-asserted-by":"publisher","award":["BFP\/GRG\/HSS\/24\/034"],"award-info":[{"award-number":["BFP\/GRG\/HSS\/24\/034"]}],"id":[{"id":"10.13039\/100020552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020552","name":"Ministry of Higher Education, Research and Innovation","doi-asserted-by":"publisher","award":["BFP\/GRG\/HSS\/24\/069"],"award-info":[{"award-number":["BFP\/GRG\/HSS\/24\/069"]}],"id":[{"id":"10.13039\/100020552","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00210-025-04727-2","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:55:15Z","timestamp":1761890115000},"page":"5285-5301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incensole enhances anti-tumor immunity and inhibits melanoma progression by modulating macrophage polarization and suppressing metastasis"],"prefix":"10.1007","volume":"399","author":[{"given":"Fatemeh","family":"Jamshidi-adegani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhaina","family":"Al-kindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Vakilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Al-Fahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziyeh","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Al-Adawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasar","family":"Alwahaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asem","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman","family":"Al-Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"4727_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.phytochem.2019.01.007","volume":"161","author":"A Al-Harrasi","year":"2019","unstructured":"Al-Harrasi A, Csuk R, Khan A, Hussain J (2019) Distribution of the anti-inflammatory and anti-depressant compounds: Incensole and incensole acetate in genus Boswellia. Phytochemistry 161:28\u201340","journal-title":"Phytochemistry"},{"key":"4727_CR2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","volume":"81","author":"NR Anderson","year":"2021","unstructured":"Anderson NR, Minutolo NG, Gill S, Klichinsky M (2021) Macrophage-based approaches for cancer immunotherapy. Cancer Res 81:1201\u20131208","journal-title":"Cancer Res"},{"key":"4727_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1189\/jlb.0310153","volume":"88","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Lewis CE (2010) NF-\u03baB as a central regulator of macrophage function in tumors. J Leukoc Biol 88:877\u2013884","journal-title":"J Leukoc Biol"},{"key":"4727_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni1001-907","volume":"2","author":"C Bogdan","year":"2001","unstructured":"Bogdan C (2001) Nitric oxide and the immune response. Nat Immunol 2:907\u2013916","journal-title":"Nat Immunol"},{"key":"4727_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0008-6363(98)00228-4","volume":"41","author":"A Bouloumi\u00e9","year":"1999","unstructured":"Bouloumi\u00e9 A, Schini-Kerth VB, Busse R (1999) Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res 41:773\u2013780","journal-title":"Cardiovasc Res"},{"key":"4727_CR6","unstructured":"Care IoLARCo, Animals UoL (1986) Guide for the care and use of laboratory animals. US Department of Health and Human Services, Public Health Service, National Institutes of Health"},{"key":"4727_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.colsurfb.2016.04.001","volume":"144","author":"B Carletto","year":"2016","unstructured":"Carletto B, Berton J, Ferreira TN, Dalmolin LF, Paludo KS, Mainardes RM, Farago PV, Favero GM (2016) Resveratrol-loaded nanocapsules inhibit murine melanoma tumor growth. Colloids Surf, B 144:65\u201372","journal-title":"Colloids Surf, B"},{"key":"4727_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/cvr\/cvr233","volume":"92","author":"WS Cheang","year":"2011","unstructured":"Cheang WS, Wong WT, Tian XY, Yang Q, Lee HK, He G-W, Yao X, Huang Y (2011) Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db\/db mice. Cardiovasc Res 92:267\u2013275","journal-title":"Cardiovasc Res"},{"key":"4727_CR9","doi-asserted-by":"publisher","first-page":"1057943","DOI":"10.1155\/2020\/1057943","volume":"2020","author":"R Duan","year":"2020","unstructured":"Duan R, Liang X, Chai B, Zhou Y, Du H, Suo Y, Chen Z, Li Q, Huang X (2020) Isorhamnetin induces melanoma cell apoptosis via the PI3K\/Akt and NF-\u03baB pathways. BioMed Res Int 2020:1057943","journal-title":"BioMed Res Int"},{"key":"4727_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.cps.2021.05.001","volume":"48","author":"WW Dzwierzynski","year":"2021","unstructured":"Dzwierzynski WW (2021) Melanoma risk factors and prevention. Clin Plast Surg 48:543\u2013550","journal-title":"Clin Plast Surg"},{"key":"4727_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","volume":"383","author":"AM Eggermont","year":"2014","unstructured":"Eggermont AM, Spatz A, Robert C (2014) Cutaneous melanoma. Lancet 383:816\u2013827","journal-title":"Lancet"},{"key":"4727_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.biopha.2018.06.014","volume":"105","author":"MA El-Magd","year":"2018","unstructured":"El-Magd MA, Khalifa SF, Alzahrani FAA, Badawy AA, El-Shetry ES, Dawood LM, Alruwaili MM, Alrawaili HA, Risha EF, El-Taweel FM (2018) Incensole acetate prevents beta-amyloid-induced neurotoxicity in human olfactory bulb neural stem cells. Biomed Pharmacother 105:813\u2013823","journal-title":"Biomed Pharmacother"},{"key":"4727_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbrc.2010.02.152","volume":"396","author":"M Farnebo","year":"2010","unstructured":"Farnebo M, Bykov VJ, Wiman KG (2010) The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun 396:85\u201389","journal-title":"Biochem Biophys Res Commun"},{"key":"4727_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrc1910","volume":"6","author":"D Fukumura","year":"2006","unstructured":"Fukumura D, Kashiwagi S, Jain RK (2006) The role of nitric oxide in tumour progression. Nat Rev Cancer 6:521\u2013534","journal-title":"Nat Rev Cancer"},{"key":"4727_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/onc.2009.416","volume":"29","author":"J Galon","year":"2010","unstructured":"Galon J, Dieu-Nosjean M, Tartour E, Sautes-Fridman C, Fridman W (2010) Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29:1093\u20131102","journal-title":"Oncogene"},{"key":"4727_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1006\/cyto.1996.0147","volume":"9","author":"PH Groeneveld","year":"1997","unstructured":"Groeneveld PH, Kwappenberg KM, Langermans JA, Nibbering PH, Curtis L (1997) Relation between pro-and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis. Cytokine 9:138\u2013142","journal-title":"Cytokine"},{"key":"4727_CR17","doi-asserted-by":"publisher","first-page":"e0149832","DOI":"10.1371\/journal.pone.0149832","volume":"11","author":"JL Hackler","year":"2016","unstructured":"Hackler JL, \u00d3zsv\u00e1ri B, Gyuris M, Sipos P, F\u00e1bi\u00e1n G, Moln\u00e1r E, Marton A, Farag\u00f3 N, Mih\u00e1ly J, Nagy LI (2016) The curcumin analog C-150, influencing NF-\u03baB, UPR and Akt\/Notch pathways has potent anticancer activity in vitro and in vivo. PLoS ONE 11:e0149832","journal-title":"PLoS ONE"},{"key":"4727_CR18","doi-asserted-by":"crossref","unstructured":"Han Y, Zhu L, Wu W, Zhang H, Hu W, Dai L, Yang Y (2020) Small molecular immune modulators as anticancer agents. Adv Exp Med Biol 1248:547\u2013618","DOI":"10.1007\/978-981-15-3266-5_22"},{"key":"4727_CR19","doi-asserted-by":"publisher","first-page":"e0202065","DOI":"10.1371\/journal.pone.0202065","volume":"14","author":"S He","year":"2019","unstructured":"He S, Carman CV, Lee JH, Lan B, Koehler S, Atia L, Park CY, Kim JH, Mitchel JA, Park J-A (2019) The tumor suppressor p53 can promote collective cellular migration. PLoS ONE 14:e0202065","journal-title":"PLoS ONE"},{"key":"4727_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0140-6736(86)92571-7","volume":"2","author":"C Hollands","year":"1986","unstructured":"Hollands C (1986) The animals (scientific procedures) act 1986. Lancet (London, England) 2:32\u201333","journal-title":"Lancet (London, England)"},{"key":"4727_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/14656566.2020.1828348","volume":"22","author":"M Julve","year":"2021","unstructured":"Julve M, Clark JJ, Lythgoe MP (2021) Advances in cyclin-dependent kinase inhibitors for the treatment of melanoma. Expert Opin Pharmacother 22:351\u2013361","journal-title":"Expert Opin Pharmacother"},{"key":"4727_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.03-0329fje","volume":"17","author":"Y-J Jung","year":"2003","unstructured":"Jung Y-J, Isaacs JS, Lee S, Trepel J, Neckers L (2003) IL-1\u03b2 mediated up-regulation of HIF-l\u03b1 via an NFkB\/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17:1\u201322","journal-title":"FASEB J"},{"key":"4727_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","volume":"42","author":"A Karimian","year":"2016","unstructured":"Karimian A, Ahmadi Y, Yousefi B (2016) Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage. DNA Repair 42:63\u201371","journal-title":"DNA Repair"},{"key":"4727_CR24","doi-asserted-by":"publisher","first-page":"1166487","DOI":"10.3389\/fimmu.2023.1166487","volume":"14","author":"SU Khan","year":"2023","unstructured":"Khan SU, Khan MU, Azhar Ud Din M, Khan IM, Khan MI, Bungau S, Hassan SSu (2023) Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy. Front Immunol 14:1166487","journal-title":"Front Immunol"},{"key":"4727_CR25","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/ijc.25182","volume":"127","author":"O Kholmanskikh","year":"2010","unstructured":"Kholmanskikh O, van Baren N, Brasseur F, Ottaviani S, Vanacker J, Arts N, van der Bruggen P, Coulie P, De Plaen E (2010) Interleukins 1\u03b1 and 1\u03b2 secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens. Int J Cancer 127:1625\u20131636","journal-title":"Int J Cancer"},{"key":"4727_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1200\/JCO.2007.12.7837","volume":"26","author":"EL Korn","year":"2008","unstructured":"Korn EL, Liu P-Y, Lee SJ, Chapman J-AW, Niedzwiecki D, Suman VJ, Moon J, Sondak VK, Atkins MB, Eisenhauer EA (2008) Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol 26:527\u2013534","journal-title":"J Clin Oncol"},{"key":"4727_CR27","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari N, Dwarakanath B, Das A, Bhatt AN (2016) Role of interleukin-6 in cancer progression and therapeutic resistance. Tumor Biol 37:11553\u201311572","journal-title":"Tumor Biol"},{"key":"4727_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","volume":"12","author":"M Li","year":"2022","unstructured":"Li M, He L, Zhu J, Zhang P, Liang S (2022) Targeting tumor-associated macrophages for cancer treatment. Cell Biosci 12:85","journal-title":"Cell Biosci"},{"key":"4727_CR29","doi-asserted-by":"publisher","first-page":"154612","DOI":"10.1016\/j.phymed.2022.154612","volume":"109","author":"Q-P Liu","year":"2023","unstructured":"Liu Q-P, Chen Y-Y, An P, Rahman K, Luan X, Zhang H (2023) Natural products targeting macrophages in tumor microenvironment are a source of potential antitumor agents. Phytomedicine 109:154612","journal-title":"Phytomedicine"},{"key":"4727_CR30","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1016\/j.cell.2022.06.010","volume":"185","author":"JO Lundberg","year":"2022","unstructured":"Lundberg JO, Weitzberg E (2022) Nitric oxide signaling in health and disease. Cell 185:2853\u20132878","journal-title":"Cell"},{"key":"4727_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0893-133X(01)00292-5","volume":"26","author":"JL Madrigal","year":"2002","unstructured":"Madrigal JL, Hurtado O, MaA M, Lizasoain I, Lorenzo P, Castrillo A, Bosc\u00e1 L, Leza JC (2002) The increase in TNF-\u03b1 levels is implicated in NF-\u03baB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 26:155\u2013163","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"4727_CR32","first-page":"555","volume":"34","author":"GH Mahabeleshwar","year":"2007","unstructured":"Mahabeleshwar GH, Byzova TV (2007) Angiogenesis in melanoma.\u00a0Seminars in oncology. Elsevier 34(6):555\u2013565","journal-title":"Elsevier"},{"key":"4727_CR33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cps.2021.06.008","volume":"48","author":"S Massand","year":"2021","unstructured":"Massand S, Neves RI (2021) Emerging therapies in the treatment of advanced melanoma. Clin Plastic Surg 48:713\u2013733","journal-title":"Clin Plastic Surg"},{"key":"4727_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030564","volume":"13","author":"MF Mercogliano","year":"2021","unstructured":"Mercogliano MF, Bruni S, Mauro F, Elizalde PV, Schillaci R (2021) Harnessing tumor necrosis factor alpha to achieve effective cancer immunotherapy. Cancers 13:564","journal-title":"Cancers"},{"key":"4727_CR35","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/jcbfm.2008.28","volume":"28","author":"A Moussaieff","year":"2008","unstructured":"Moussaieff A, NaA S, Tsenter J, Grigoriadis S, Simeonidou C, Alexandrovich AG, Trembovler V, Ben-Neriah Y, Schmitz ML, Fiebich BL (2008) Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii. J Cereb Blood Flow Metab 28:1341\u20131352","journal-title":"J Cereb Blood Flow Metab"},{"key":"4727_CR36","doi-asserted-by":"publisher","first-page":"32335","DOI":"10.1039\/D3RA06335F","volume":"13","author":"I Nayila","year":"2023","unstructured":"Nayila I, Sharif S, Lodhi MS, Rehman MFU, Aman F (2023) Synthesis, characterization and anti-breast cancer potential of an incensole acetate nanoemulsion from Catharanthus roseus essential oil; in silico, in vitro, and in vivo study. RSC Adv 13:32335\u201332362","journal-title":"RSC Adv"},{"key":"4727_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.sajb.2024.07.026","volume":"172","author":"I Nayila","year":"2024","unstructured":"Nayila I, Sharif S, Lodhi MS, Ullah R, Alotaibi A, Maqbool T (2024) Targeting the WWP1 gene with incensole acetate nanoemulsion: a novel therapeutic strategy for breast cancer. S Afr J Bot 172:415\u2013429","journal-title":"S Afr J Bot"},{"key":"4727_CR38","unstructured":"Organization WH (2022) Estimated number of new cases from 2020 to 2040. Incidence, Both sexes, age [0\u201385+]. https:\/\/gco.iarc.fr\/today\/home"},{"key":"4727_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071791","volume":"12","author":"C R\u00e9b\u00e9","year":"2020","unstructured":"R\u00e9b\u00e9 C, Ghiringhelli F (2020) Interleukin-1\u03b2 and cancer. Cancers 12:1791","journal-title":"Cancers"},{"key":"4727_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1517\/14712598.7.3.345","volume":"7","author":"AI Riker","year":"2007","unstructured":"Riker AI, Radfar S, Liu S, Wang Y, Khong HT (2007) Immunotherapy of melanoma: a critical review of current concepts and future strategies. Expert Opin Biol Ther 7:345\u2013358","journal-title":"Expert Opin Biol Ther"},{"key":"4727_CR41","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/bjc.1997.486","volume":"76","author":"P Salven","year":"1997","unstructured":"Salven P, Heikkil\u00e4 P, Joensuu H (1997) Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br J Cancer 76:930\u2013934","journal-title":"Br J Cancer"},{"key":"4727_CR42","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.4161\/cc.10.24.18552","volume":"10","author":"H Siemens","year":"2011","unstructured":"Siemens H, Jackstadt R, H\u00fcnten S, Kaller M, Menssen A, G\u00f6tz U, Hermeking H (2011) MiR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 10:4256\u20134271","journal-title":"Cell Cycle"},{"key":"4727_CR43","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1039\/c6ib00105j","volume":"8","author":"TD Smith","year":"2016","unstructured":"Smith TD, Tse MJ, Read EL, Liu WF (2016) Regulation of macrophage polarization and plasticity by complex activation signals. Integr Biol (Camb) 8:946\u2013955","journal-title":"Integr Biol (Camb)"},{"key":"4727_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1200\/OP.21.00686","volume":"18","author":"B Switzer","year":"2022","unstructured":"Switzer B, Puzanov I, Skitzki JJ, Hamad L, Ernstoff MS (2022) Managing metastatic melanoma in 2022: a clinical review. JCO Oncol Pract 18:335\u2013351","journal-title":"JCO Oncol Pract"},{"key":"4727_CR45","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1200\/JCO.2010.31.5812","volume":"29","author":"JF Thompson","year":"2011","unstructured":"Thompson JF, Soong S-J, Balch CM, Gershenwald JE, Ding S, Coit DG, Flaherty KT, Gimotty PA, Johnson T, Johnson MM (2011) Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol 29:2199\u20132205","journal-title":"J Clin Oncol"},{"key":"4727_CR46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/cas.13433","volume":"109","author":"H Tsukamoto","year":"2018","unstructured":"Tsukamoto H, Fujieda K, Senju S, Ikeda T, Oshiumi H, Nishimura Y (2018) Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity. Cancer Sci 109:523\u2013530","journal-title":"Cancer Sci"},{"key":"4727_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137:413\u2013431","journal-title":"Cell"},{"key":"4727_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.niox.2008.05.003","volume":"19","author":"DA Wink","year":"2008","unstructured":"Wink DA, Ridnour LA, Hussain SP, Harris CC (2008) The reemergence of nitric oxide and cancer. Nitric Oxide: Biology and Chemistry\/official Journal of the Nitric Oxide Society 19:65","journal-title":"Nitric Oxide: Biology and Chemistry\/official Journal of the Nitric Oxide Society"},{"key":"4727_CR49","doi-asserted-by":"publisher","first-page":"e71130","DOI":"10.1371\/journal.pone.0071130","volume":"8","author":"CH Yang","year":"2013","unstructured":"Yang CH, Yue J, Sims M, Pfeffer LM (2013) The curcumin analog EF24 targets NF-\u03baB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS ONE 8:e71130","journal-title":"PLoS ONE"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04727-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04727-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04727-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T04:03:54Z","timestamp":1776225834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04727-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4727"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04727-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics, consent to participate, and consent to publish declarations"}},{"value":"All animal experiments complied with the UK Animals Act (Hollands 1986) and the NIHGuide for the Care and Use of Laboratory Animals (Care and Animals, 1986). Studies adheredto ethical standards set by the National Committee of Bioethics, and the in vivo study wasapproved by the Animal Ethics Committee at the University of Nizwa (Approval ID:VCGSR\/AREC\/06\/2023). Animal welfare was prioritized, with procedures followingapproved protocols, ensuring proper housing, nutrition, and reproductive care in a controlledlaboratory setting.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of animal rights"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of potential conflicts of interest"}}]}}